When: $128-130 accumulation zone floor, stabilized, capitulation volume

Then: Add 25%, stop $125

When: Close >$148 (200 SMA retest), volume confirmation

Then: Trim 15-20%, let rest ride with trailing stop

When: Close <$125, Volume >10M

Then: Exit position, pre-committed Underweight/Sell reassessment

When: Mid-October print — operating margin near 14% organic, FCF coverage <95%

Then: Reassess toward Underweight or Sell

When: Margin holds >15% organically + international momentum sustains + FCF coverage rebuilds above 100%

Then: Maintain or upgrade Hold

When: GLP-1 fresh-foods revenue disclosure shows material category shift

Then: Upgrade to Overweight

HOLD existing position; do not add; consider trimming 10-15% into bounces toward 138-140; stop at 125, tighten to 130 if 135.72 breaks on a closing basis

• Decade-low FCF multiple reflects market pricing in deterioration, not error—earnings down 14% YoY, trajectory moving wrong direction
• Technical setup shows death cross since mid-May with widening 50/200 SMA gap, MACD histogram negative and expanding for 3 sessions, price hugging lower Bollinger band at 135.72 as continuation not reversal pattern
• 1.00x dividend coverage ratio means $7.64B in dividends paid against $7.67B in FCF—zero margin of safety, one shock away from debt-funded dividend
• Net debt increased from $34B to $40B over four years; defending dividend with further borrowing manufactures appearance of safety
• GLP-1 fresh foods thesis is 24-36 month horizon; Siete Foods and Bare Foods still in integration, goodwill balance jumped meaningfully
• 10-year Treasury at ~5%, Fed cuts only 7% priced for 2026, making 4.33% dividend yield uncompetitive vs. risk-free rate
• Asymmetric risk-reward claim flawed—200 SMA declining (145.5 from 146 in July), no fundamental catalyst or technical reversal present
• Break below 135.72 opens swift move to 133.50 then 130; 10-point drop from 136 to 125 is 7% loss requiring nearly 2 years of dividends to recover

→ vs aggressive: Decade-low valuation framing is flawed—market pricing in deterioration (earnings down 14% YoY, declining FCF), not making an error; 1.00x dividend coverage is a warning sign, not a margin of safety

→ vs aggressive: Technicals dismissed as 'lagging indicators' but death cross since mid-May, MACD negative September 8th, and price at lower Bollinger band in downtrend is continuation pattern, not reversal; lower highs and lower lows confirm downtrend

→ vs aggressive: Asymmetric risk-reward assumes frictionless path higher and mean reversion to 200 SMA—but 200 SMA is declining and mean reversion requires fundamental catalyst or technical reversal, neither present

→ vs neutral: 1.00x dividend coverage warrants smaller position or tighter stop; 7% price loss from 136 to 125 requires nearly 2 years of dividend collection to recover, which is unfavorable risk-adjusted math

→ vs aggressive: Bond yield competition 'already priced in' is unverifiable; with 10-year near 5% and 93% probability of no cuts, 4.33% dividend yield is uncompetitive and equity risk premium keeps compressing

HOLD existing position; collect dividend as cash without reinvesting until technical confirmation; scale in only on capitulation below 133 or breakout above 139.20

• Forward multiple of 15.22 versus 21-22 for peers is compelling but insufficient alone to add
• Technical analysis shows lower highs and lower lows (continuation pattern), not a base forming
• MACD histogram turned negative September 8th and expanding lower for three sessions
• Dividend coverage at exactly 1.00x is razor-thin; one bad quarter could signal income story breaking
• GLP-1 pivot thesis (Siete Foods, Bare Foods acquisitions) is 24-36 month horizon, not immediate catalyst
• 10-year approaching 5% with 93% probability of no Fed cuts in 2026 creates hostile macro backdrop for high dividend equities
• First add tranche should be pushed to confirmed breakdown below 133 with capitulation volume, not 135
• Second tranche at 128 only on technical reversal signal
• Stop at 125 remains defensible; 130 is psychological support that would get clipped by normal volatility
• Asymmetry exists: downside to 130 is about 5%, upside to 50 SMA at 138 is 1%, to 200 SMA at 145 is 8-9%

→ vs aggressive: Pattern-matching valuation comfort as base formation; buying into confirmed downtrend with broken momentum; 1.00x dividend coverage framed as non-event despite razor-thin margin for error

→ vs conservative: Trimming at 138-140 zone is selling into resistance where sellers are camping, locking in losses for less than 2% premium; tightening stop from 125 to 130 at 135.72 (less than 1 ATR) will get clipped by normal volatility in range-bound tape; dismissal of valuation ignores asymmetry already in price